文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 临床医学 > 2008 Shen J--Bone marrow MRI as predictors of outcome in hemopoietic stem cell transplantation
侵权投诉

2008 Shen J--Bone marrow MRI as predictors of outcome in hemopoietic stem cell transplantation

MRS

1885

patientsinclass1havenoneofthecharacteristics,patientsinclass2haveoneortwoofthecharacteristicsandpatientsinclass3haveallthreecharacteristics.WhenHSCTisattempted,thepatientsarethenassignedtooneoftwoconditioningregimensonthebasisoftheirPesaroriskclassification.Theconditioningregimenusescytotoxicagentstosuppressbonemarrowactivityandimmunitybeforehematopoieticstemcellinfusion,therebyhelpingtominimizehematopoieticstemcellrejection.Low-riskpatientswithPesaroclass1orclass2diseasehaveexcellenttogoodresultsafterHSCT,whilepatientswithclass3diseasehavepoorresultsmainlyfromahighrejectionrateduetoattenuatedconditioning[6].Forclass1,class2andclass3patients,theprobabilityofsurvivalandevent-freesurvivalare95%and90%,86%and82%,and87%and63%,respectively[7].Newerpreparatoryregimenshavesubstantiallyimprovedthesurvivalrateto93%withtherejectionratefallingfrom30%to8%inpatientswithclass3diseaseyoungerthan17yearsofage[8].WhilethePesaroclassificationisuseful,ithasinherentlimitations.Forexample,hepatomegalyissubjectivelydefinedasaliveredgepalpable2cmormorebelowthecostalmargin,whilehistologicalevaluationofportalfibrosisisnecessarilyinvasive.Thissaid,todate,abetterpre-transplantationriskstratificationassessmentisnotavailable[9].

MRimagingcanaccuratelydemonstratered/yellowbonemarrowdistributionandconversionpatterns[10,11].ItcanrevealabnormalappearanceswithprolongedT1marrowvaluesbeingusedtoshowimprovementaftertreatmentinhematologicalmalignancies,suchasleukemia,myelomaandlymphoma[12,13].However,afewstudieshavespecificallyaddressedtheMRbonemarrowimaginginthalassaemia[14,15].Theradiographicfeaturesofbeta-thalassemiaaredueinlargeparttomarrowhyperplasiainresponsetochronicanemia[14].OnMRimaging,redmarrowproliferationwasrevealedaspersistenceorreconversionofredmarrowareasandmaybepresentdespitehypertransfusiontherapy.Ontheotherhand,repeatedtransfusiontherapyandexcessivegastrointestinalabsorptionofironleadtohemosiderosis,whichmayoccurinactiveredmarrowregionsdespitechelationtherapyandresultinsubstantiallyreducedbonemarrowMRsignalduetomagneticsusceptibilityeffectsandassociatedT2shortening[15].However,bonemarrowMRchangesafterHSCThadnotbeendescribedinpatientswiththalassemiayet.Inparticular,thebenefitofMRimagingassessmentofbonemarrowinpatientspriortoHSCThasneverbeenspecificallyaddressed.ItisunknownwhetherMRimagingispredictiveofpatientoutcomefollowingHSCTforbeta-thalassemiamajor.

Inthisstudy,MRassessmentofthemarrowintheproximalfemurwascorrelatedwithclinicaloutcomefollowingHSCTinbeta-thalassemiamajorpatientstodeterminewhetherMRappearanceswerepredictiveofsuccessfuloutcome.

Materialsandmethods

Patients

BetweenMay1998andMay2007,prospectivefemoralmarrowMRimagingexaminationwereperformedin27childrenwithbeta-thalassemiamajorpreparedforalloge-neicHSCT.ThestudyprotocolincludingMRexaminationwasapprovedbytheHumanResearchCommitteeofourinstitution.Informedconsentwasobtainedfromtheparentsofallparticipatingpatientsfollowingdetailedexplanation.Therewere12boysand15girls(meanageatthetimeofHSCT:6years7months,range:2–13years).Thediagnosisofbeta-thalassemiamajorwasmadebyhemoglobinelectrophoresisorgenotypicalanalysisinallpatients.Meandurationofsymptomsofthalassemiawas5years3months(range:1–11years).Eighteenpatientshadbeentreatedwithanadequatebloodtransfusionregime(i.e.,hemoglobinlevelmaintainedat90–120g/l),whileninepatientsreceivedaninadequatetransfusionregime(hemoglobinlevelmaintainedat60–90g/l).Eightpatientshadbeenchelatedadequatelywithdeferoxamine,i.e.,deferoxaminetherapyinitiatedwithin18monthsoffirsttransfusionandadministeredsubcutaneouslyfor10hcontinuouslyfor5dayseachweek.Thirteenpatientswerechelatedinadequatelywithdeferoxamine,whiletheremainingsixpatientsdidnotreceivechelation.Threepatientshadpreviouslyundergonesplenectomy.Measure-mentofserumferritinandliverbiopsywasperformedinallpatientswithin7daysofMRimaging.BiopsymaterialwasstainedwithPrussianbluetoevaluatehemosiderosisandstainedusingthemethodofMassontrichromestaining[16]toevaluateportalfibrosis.HSCT

BeforeHSCT,14(52%)and13(48%)ofthe27patientswereclassifiedasclass2andclass3atthetimeofHSCTaccordingtoPesaroriskclassification,respectively[1].Theconditioningregimenin12patientsconsistedofbusulphan(14mg/kgondays 9to 6)andcyclophos-phamide(200mg/kgondays 5to 2).Fifteenpatientsreceivedeitheradecreaseddoseofcyclophosphamide(150mg/kg;tenpatients)oranincreaseddoseofbusulphan(16mg/kg;fivepatients).Additionalimmunosuppressiveagentswereaddedtotheconditioningregimentolessengraftrejection.Theseincludedantithymocyteglobulinglobulin(30mg/kg/day)orantilymphocyticglobulin(12.5mg/kg/day)for3–5daysinallpatientsandfludarabine(25mg/m2/day)for2–5daysin12patients.Oneclass2patientandoneclass3patientdiedwhilereceivingtheconditioningregimen,onefromheartfailure,theotherfromhepaticveno-occlusivedisease.Theremaining25patientsunderwentHSCT.Detailsofrelevantpre-HSCTfeaturesaregiveninTable1.Ofthe25patientsundergoingHSCT,17patientsreceivedumbilicalcord

上一页第2页

你可能喜欢

热门文档

相关文档

  • 双极氧化2008-shen (PPTminimizer)

    with high MW and then to decrease the load in next step 30 Methods to Improve Electrochemical Treatment Effect of Dye Wastewater ZM Shen*, D Wu, J....

  • 聚苯乙炔

    Science, 2008, 319, 1229—1232 苯乙烯-丙稀酰胺共聚物功能化石墨烯: Shen J F, Hu Y Z, Li C, Qin C, Ye M X. Synthesis of amphiphilic graphene ...

  • 软件工程选题报告

    Strueturalhealthmonitoring,2008(2):91,102. [18] Shen,J. , Cheng , K.E.,Cho,Y.Hiltz.S.R. and Bieber,M.(2000) Evaluation of an Online ...

  • HPLC测定苏木中的巴西苏木素和原苏木素B

    苏木降糖活性成分研究〔 2008. 院药物研究所, Shen J, Zhang H, Lin H Y, et al. Brazilein protects the brain against focal cerebral ischemia reperfusion ...

  • SCI影响因子分析

    (up to Dec. 13, 2008) Table 1 The most highly cited articles in JZUS-A from 2000 to 2008 (up to Dec. 13, 2008) Citations 16 Author SHEN J ...

  • 宏基因组学

    2008 宏基因组学 (M etageno ics)的研究现状和发展趋势 [ J]. 环境科学学报, 28( 2 ): 209- 218 . m H e J Z Zhang L M, Shen J P, et al....

  • SUS304ss包埋粉末渗铝的耐蚀性能

    Sci. Eng., 2008, 21: 97-100 ( ? , ??. ? ??? ??? ?? [J]. ?? ? ? , 2008, 21: 97-100) [9] Li L F, Shen J N, Li M C, et...

  • 倪金凤

    J. Bacteriol. 190:3006-17. 8. Zhang S, Wei W., Hou. G, Zhang C, Liang P., Ni J., Sheng D., Shen Y. (2008) Archaeal DNA helicase HerA...

  • 石墨烯的制备方法及其应用特性

    (2) 19.Hao R.Qian W.Zhang L H Aqueous dispersions of TCNQ-anion-stabilized graphene sheets 2008(48) 20.Shen J F.Hu Y Z.Li C Layer-by-layer ...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email